Skip to content

Outcomes in CArdiogenic SHock Patients Treated by MEchanical Circulatory suppoRt devicE : Impact of Shock Team

Outcomes in CArdiogenic SHock Patients Treated by MEchanical Circulatory suppoRt devicE : Impact of Shock Team

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05309980
Acronym
CASHMERE
Enrollment
250
Registered
2022-04-04
Start date
2021-04-01
Completion date
2022-04-15
Last updated
2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Shock, Shock Team, Short Term Mechanical Circulatory Support

Keywords

Extra Corporeal Membrane Oxygenation, Cardiogenic Shock, Impella, Shock Team, Long Term Mechanical Circulatory Support

Brief summary

In this before-after monocenter study, the authors teste the hypothesis that the implementation of a dedicated shock team could improve the outcome of patients with refractory cardiogenic shock assisted by mechanical circulatory support.

Detailed description

Short Term Mechanical Circulatory Support (STMCS) are the last resort therapeutics when refractory cardiogenic shock occurs. Growing technical possibilities like impella make the right choice at the right time challenging. At Bordeaux University Hospital, we have gathered the main protagonists which are the surgeon, the interventional cardiologist,and the intensivist as a shock team in January 2013. From that time, diagnosis of refractory cardiogenic shock triggers a multidisciplinary meeting driven by a common algorithm. The objective of this study is to perform a before-after comparison between decision of STMCS for refractory cardiogenic shock without shock team from january 2007 to january 2013 and after implementation of the shock team from April 2013 to April 2019.

Interventions

OTHERstandard of care

retrospective study : standard of care

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cardiogenic shock * \>1 sign of refractory cardiogenic shock : Dobutamine \>10µg/kg/mn, epinephrine\>0.25µg/kg/mn or Milrinone \> 0.5µg/kg/mn ; ScvO2\<55% ; pO2/FiO2\<100 * No major counter indication to short term mechanical circulatory support : SOFA score \> 15, prolonged cardiac arrest, severe chronic disease, direct LVAD implantation or heart transplantation, counter indication for systemic anticoagulation

Exclusion criteria

* Age \< 18years * Post cardiotomy cardiogenic shock * Implantation of Impella 2.5 alone * Implantation of Intra Aortic Balloon Pump alone

Design outcomes

Primary

MeasureTime frameDescription
Vital statusOne year after short term mechanical circulatory support initiationProportion of patients alive

Secondary

MeasureTime frameDescription
Vital status30 days after short term mechanical circulatory support initiationproportion of patients alive
Lenght of stayup to Intensive Care Unit discharge, an average of 15 daysIntensive Care Unit length of stay
Long term mechanical circulatory supportup to intensive care unit discharge, an average of 15 daysproportion of patients bridged to long term mechanical circulatory support
Heart transplantationup to intensive care unit discharge, an average of 15 daysproportion of patients bridged to heart transplantation
Weaning from short term mechanical circulatory supportup to seven days from weaning attemptproportion of patients sucessfully weaned from short term mechanical circulatory support
New renal replacement therapyup to intensive care unit discharge, an average of 15 daysproportion of patients needing renal replacement therapy
Limb ischaemiathrough short term mechanical circulatory support weaning, an average of 6 daysproportion of patients with limb ischaemia
Strokethrough short term mechanical circulatory support weaning, an average of 6 daysproportion of patients with stroke
Short term mechanical circulatory support durationthrough short term mechanical circulatory support weaning, an average of 6 daysShort term mechanical circulatory support duration
Severe haemorragethrough short term mechanical circulatory support weaning, an average of 6 daysproportion of patients with severe haemorrage (massive haemorrhage according to SFAR or use of Novoseven or rescue surgery for bleeding)
Extra Corporeal Membrane Oxygenation circuit clottingthrough short term mechanical circulatory support weaning, an average of 6 daysproportion of patients in which Extra Corporeal Membrane Oxygenation circuit clotting occured
Sepsisup to intensive care unit discharge, an average of 15 daysproportion of patients in which sepsis occured

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026